Related Experiment Video
Updated: Mar 27, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Effects of adrenergic receptor modulators on nuclear LCC‑channels in Purkinje neurons
Olena Kotyk1, Serhii Nadtoka1, Tetiana Vynohradova1
1Department of Cellular Membranology, Bogomoletz Institute of Physiology, Kyiv, Ukraine.
Abstract:
Large conductance cation channels (LCC‑channels), located in the nuclear membrane, are potential mediators of potassium (K+) countercurrent during calcium ion (Ca2+) release from intracellular stores. This study examined the effects of epinephrine, norepinephrine, isoprenaline, and propranolol on the electrophysiological properties of these channels to evaluate their potential as blocking agents in future studies of LCC‑channel involvement in Ca2+ release. The patch‑clamp method, using voltage‑clamp mode and a nucleus‑attached configuration, was employed to record currents passing through LCC‑channels in Purkinje cell nuclei. The effectiveness of Ca2+ blocking was estimated by analyzing changes in current amplitude and the probability of the channels being in an open state. All tested adrenergic receptor modulators decreased current amplitude through LCC‑channels at negative membrane potentials to varying extents, while no changes in amplitude were found for positive applied potentials for any compound. Epinephrine, norepinephrine, and propranolol demonstrated blocking capabilities comparable to nicotinic acetylcholine receptor (nAChR) modulators under similar conditions. Notably, only norepinephrine significantly inhibited the open‑state probability of LCC‑channels, whereas isoprenaline increased this parameter and induced rapid flickering. Furthermore, isoprenaline produced a greater reduction in current amplitude through LCC‑channels than the other compounds.
More Related Videos
08:11Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...